Immediate Impact
2 from Science/Nature 51 standout
Citing Papers
Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020-2023
2024 Standout
Applications of SGLT2 inhibitors beyond glycaemic control
2024 Standout
Works of Robert Feldman being referenced
Incidence and Predictors of Primary Nonadherence to Sodium Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Agonists in a Large Integrated Healthcare System
2022
Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robert Feldman | 101 | 84 | 24 | 97 | 21 | 428 | |
| F. Sprangers | 132 | 36 | 2 | 45 | 16 | 454 | |
| Bruno Rushforth | 171 | 44 | 15 | 134 | 22 | 445 | |
| Prakash Laud | 109 | 81 | 2 | 21 | 16 | 491 | |
| Summer V. Allen | 249 | 37 | 9 | 49 | 21 | 508 | |
| Kelly Howells | 179 | 40 | 11 | 64 | 18 | 374 | |
| Kelly P. McCarrier | 131 | 41 | 4 | 58 | 36 | 472 | |
| M. Kathleen Figaro | 108 | 43 | 1 | 70 | 15 | 488 | |
| Ruben Pinkhasov | 143 | 52 | 5 | 26 | 16 | 438 | |
| John C. Ausiello | 112 | 35 | 12 | 75 | 13 | 495 | |
| Karen Schmidt | 103 | 29 | 2 | 71 | 37 | 509 |
All Works
Login with ORCID to disown or claim papers
Loading papers...